Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine releaseRichard B Rothman, Christina M Dersch, Subramaniam Ananthan, et al.
Synapse (New York, N.Y.)|February 9, 2002
Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter bindingRichard B Rothman, Christina M Dersch, F Ivy Carroll, et al.
Synapse (New York, N.Y.)|July 6, 2004
Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporterAyon Nandi, Christina M Dersch, Manish Kulshrestha, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transportersRichard B Rothman, Robert D Clark, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2005
(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membraneXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Journal of the American Pharmacists Association : Japha|January 24, 2015
Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causationEd J Hendricks, Richard B Rothman, David A Bryman, et al.
Biochemical Pharmacology|September 28, 2007
Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addictionRichard B Rothman, Michael H Baumann, Thomas E Prisinzano, et al.
Life Sciences|May 7, 2002
Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failureNora V Bergasa, Richard B Rothman, Erik Mukerjee, et al.
Peptides|January 22, 2003
Endogenous corticotropin releasing factor regulates adrenergic and opioid receptorsRichard B Rothman, Nga Vu, Heng Xu, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonistsSantosh S Kulkarni, Barbara Nightingale, Christina M Dersch, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine releaseRichard B Rothman, Christina M Dersch, Subramaniam Ananthan, et al.
Synapse (New York, N.Y.)|February 9, 2002
Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter bindingRichard B Rothman, Christina M Dersch, F Ivy Carroll, et al.
Synapse (New York, N.Y.)|July 6, 2004
Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporterAyon Nandi, Christina M Dersch, Manish Kulshrestha, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transportersRichard B Rothman, Robert D Clark, John S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2005
(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membraneXiaoying Wang, Michael H Baumann, Heng Xu, et al.
Journal of the American Pharmacists Association : Japha|January 24, 2015
Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causationEd J Hendricks, Richard B Rothman, David A Bryman, et al.
Biochemical Pharmacology|September 28, 2007
Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addictionRichard B Rothman, Michael H Baumann, Thomas E Prisinzano, et al.
Life Sciences|May 7, 2002
Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failureNora V Bergasa, Richard B Rothman, Erik Mukerjee, et al.
Peptides|January 22, 2003
Endogenous corticotropin releasing factor regulates adrenergic and opioid receptorsRichard B Rothman, Nga Vu, Heng Xu, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonistsSantosh S Kulkarni, Barbara Nightingale, Christina M Dersch, et al.
Pageof 16